呼吸支持治疗危重哮喘的临床观察和分析  

Clinical observation and analysis about the severe asthma cured by respiratory support

作　　者：曾建明[1] 王新[1] 莫郁苓[1] 田立景[1] 

机构地区：[1]德阳市人民医院呼吸内科,618000

出　　处：《中国实用医药》2010年第21期47-49,共3页China Practical Medicine

摘　　要：目的探讨呼吸(有创呼吸机)支持治疗危重支气管哮喘的临床效果。方法回顾分析2005年11月至2009年11月我科呼吸支持(有创呼吸机)治疗的67例危重支气管哮喘,按是否给予呼吸支持(有创呼吸机)治疗分为治疗组和非治疗组,分析比较两组的住院天数、治愈率以及死亡率。结果治疗组住院天数12.26±0.66d明显少于非治疗组23.12±1.40d(P<0.05);治疗组治愈率为97%明显高于非治疗组的75%(P<0.05);治疗组的死亡率3%明显少于非治疗组死亡率24%(P<0.05)结论治疗组在治疗天数、治愈率、死亡率等方面均优于非治疗组。在常规哮喘治疗的基础上及时有效的呼吸支持(有创呼吸机)治疗可明显地提高治疗效果。Objective To discussing the Clinical effects of severe asthma cured by respiratory support （ invasive respiratory support）. Methods Through analyzing the therapy result about 67 cases of severe asthma which were divided into treatment group and non-treatment group by giving respiratory support or not. Results （ 1） The hospitalization days of treatment group were significantly lower than non-treatment group （ P 〈0. 05）. （ 2） the cure rate of treatment group were significantly higher than non-treatment group （ P 〈0. 05）. （ 3） the Mortality of treatment group were significantly lower than non-treatment group （ P〈 0. 05）. Conclusion The curing effects of severs asthma was significantly elevated by respiratory support.

关 键 词：危重支气管哮喘 呼吸支持 糖皮质激素 

分 类 号：R562.25[医药卫生—呼吸系统]